Gold(I) Complexes Based on Nonsteroidal Anti-Inflammatory Derivatives as Multi-Target Drugs against Colon Cancer
Open Access
- 10 October 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 63 (42) , 19769-19782
Abstract
Targeting inflammation and the molecules involved in the inflammatory process could be an effective cancer prevention and therapy strategy. Therefore, the use of anti-inflammatory strategies, such as NSAIDs and metal-based drugs, has become a promising approach for preventing and treating cancer by targeting multiple pathways involved in tumor progression. The present work describes new phosphane gold(I) complexes derived from nonsteroidal anti-inflammatory drugs as multitarget drugs against colon cancer. The antiproliferative effect of the most active complexes, [Au(L3)(JohnPhos)] (3b), [Au(L4)(CyJohnPhos)] (4a) and [Au(L4)(JohnPhos)] (4b) against colon cancer cells (Caco2-/TC7) seems to be mediated by the inhibition of the enzyme cyclooxygenase-1/2, modulation of reactive oxygen species levels by targeting thioredoxin reductase (TrxR) activity, and induction of apoptosis in cancer cells. Additionally, the three complexes exhibit high selectivity index values toward noncancerous cells. The research highlights the importance of maintaining cellular redox balance and the role of TrxR in cancer cell survival.Keywords
Funding Information
- Interreg (S1/1.1/E01116)
- Gobierno de Arag?n (B16_23R, E07_23R)
- Ministerio de Ciencia, Innovaci?n y Universidades (PID2022-136861NB-I00)
- Centro de Investigaci?n Biom?dica en Red-Fisiopatolog?a de la Obesidad y Nutrici?n (CB06/03/1012)
This publication has 90 references indexed in Scilit:
- Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectivenessMedicinal Research Reviews, 2021
- Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX‐2 and PD‐L1Angewandte Chemie, 2020
- Antiproliferative Activity of Gold(I) N‐Heterocyclic Carbene and Triphenylphosphine Complexes with Ibuprofen Derivatives as Effective Enzyme InhibitorsApplied Organometallic Chemistry, 2020
- The Thioredoxin System: A Promising Target for Cancer Drug DevelopmentChemistry – A European Journal, 2020
- A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti‐Ovarian‐Cancer Agent by Inhibiting TrxR and Activating ROS‐Mediated ERSChemistry – A European Journal, 2020
- Physical activity and the risk of colorectal cancer in Lynch syndromeInternational Journal of Cancer, 2018
- Selective Activation of a Prodrug by Thioredoxin Reductase Providing a Strategy to Target Cancer CellsAngewandte Chemie International Edition, 2018
- Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) in Metal Complexes and Their Effect at the Cellular LevelEuropean Journal of Inorganic Chemistry, 2016
- The Prodrug Platin‐A: Simultaneous Release of Cisplatin and AspirinAngewandte Chemie International Edition, 2014
- Coordination Chemistry of Gold Catalysts in Solution: A Detailed NMR StudyChemistry – A European Journal, 2012